Last updated on September 2018

A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors


Brief description of study

A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of BCD-100 (JSC BIOCAD, Russia) in Patients with Advanced Solid Tumors

Clinical Study Identifier: NCT03050047

Contact Investigators or Research Sites near you

Start Over

Svetlana Odintsova, MD

LLC BioEk
Saint-Petersburg, Russian Federation

Vladimir Moiseenko, MD

State budgetary health care institution "St. Petersburg Clinical Scientific and Practical Center of Specialized Medical Assistance (Oncological)"
Sankt Petersburg, Russian Federation